Immunotech Biopharm Ltd (HKG:6978)
Hong Kong · Delayed Price · Currency is HKD 4.270
+0.070 (1.67%)
Aug 8, 2025, 4:08 PM HKT
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 2.20 billion as of August 8, 2025. Its market cap has increased by 33.02% in one year.
Market Cap
2.20B
Enterprise Value
2.54B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.27
Market Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 2.20B, a decrease of -71.61%. That is a compound annual growth rate of -21.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 2.20B | 85.65% |
| Dec 31, 2024 | 1.18B | -54.00% |
| Dec 29, 2023 | 2.57B | 7.99% |
| Dec 30, 2022 | 2.38B | -72.51% |
| Dec 31, 2021 | 8.67B | 50.90% |
| Dec 31, 2020 | 5.74B | -25.80% |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 286.15B |
| Hansoh Pharmaceutical Group Company | 216.43B |
| Innovent Biologics | 167.61B |
| JD Health International | 167.37B |
| Akeso | 153.66B |
| Sino Biopharmaceutical | 134.13B |
| WuXi Biologics | 128.67B |
| CSPC Pharmaceutical Group | 115.02B |